Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory

Coronavirus disease 2019 (COVID-19) surveillance, in Brazil, initiated shortly after its description, in China. Our aim was to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and additional pathogens in samples from the initial phase of the outbreak in Brazil, from late February...

Descripción completa

Detalles Bibliográficos
Autores principales: Matos, Aline da Rocha, Motta, Fernando Couto, Caetano, Braulia Costa, Ogrzewalska, Maria, Garcia, Cristiana Couto, Lopes, Jonathan Christian Oliveira, Miranda, Milene, Livorati, Miriam Teresinha Furlam Prando, Abreu, André, Brown, David, Siqueira, Marilda Mendonça
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508282/
https://www.ncbi.nlm.nih.gov/pubmed/32965332
http://dx.doi.org/10.1590/0074-02760200232
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) surveillance, in Brazil, initiated shortly after its description, in China. Our aim was to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and additional pathogens in samples from the initial phase of the outbreak in Brazil, from late February to late March. From 707 samples analysed, 29 (4.1%) were SARS-CoV-2 positive. Fever and cough were their most prevalent symptoms. Co-detection of rhinovirus was observed in 2 (6.9%) cases. Additional pathogens were identified in 66.1% of the SARS-CoV-2 negative cases, mainly rhinovirus and influenza A(H1N1)pdm09. Thus, we emphasise the importance of differential diagnosis in COVID-19 suspected cases.

Ejemplares similares